Daniel Drexler, the M.D. who ran WPP’s J&J shop, leaves to join Klick
Formerly CEO of WPP’s The Neighborhood, Drexler assumes a client service role with Klick.
Most recent articles by Marc Iskowitz
Healthcare’s own ‘Undoing Project’
What two connoisseurs of human error taught the world about the mind’s inner workings has implications for healthcare marketing.
David Gideon, medical media icon and industry stalwart, dies at 75
For Gideon, honoring those who helped build the medical ad industry became a labor of love.
Media buyers form group to advance standards in POC
Among the group’s members are media agencies that had pulled healthcare ad spend from the POC channel in the wake of a scandal 10 months ago.
Acquisition fever in July: What does it mean for agencies?
Health agencies are in acquisition mode, with networks snapping up independents, and the M&A market looks poised to stay hot.
CCO firings a sign of agencies’ waning tolerance for misbehavior
Men in high advertising posts are still misbehaving, but agencies are taking the behavior more seriously now, and acting swiftly to address it.
2018 Agency 100 overview: firms adapt to stay ahead of nontraditional players
There was a resetting of healthcare agency priorities in 2017, from income mix to what’s keeping them up at night. But revenue continues its steady uptick as firms attempt to stay a step ahead of nontraditional players.
2018 Agency 100 preview: a complete guide to a year of disruption
This year’s version of the Agency 100 aims to give you the most complete guide to disruptions in the environment in which agencies operate, ranging from fresh data privacy and security worries, to newer kinds of innovation and enterprise technology work.
Quantifying pharma’s online promotional shift
Pharma brands quickened their shift toward online consumer media last year but continued to invest more on web-based professional outreach, new data show.
No sure fixes for pharma’s patent cliff
With a spate of high-margin blockbusters going off patent and a lack of replacement products, a Bernstein Research conference explored three potential solutions to the patent cliff.
